← All companies
NTLA annual net income
Intellia Therapeutics, Inc.
NTLA - CIK 0001652130
Market cap$1.70 B
Rank#2213
SEC filings687
Intellia Therapeutics, Inc. net income by year
Intellia Therapeutics, Inc. (NTLA) reported net income of -$412.69M for fiscal year 2025, as filed in its audited annual report with the SEC.
NTLA net income 2015-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$412.69M | +20.5% |
| FY 2024 | -$519.02M | -7.9% |
| FY 2023 | -$481.19M | -1.5% |
| FY 2022 | -$474.19M | -77.0% |
| FY 2021 | -$267.89M | -99.6% |
| FY 2020 | -$134.23M | +71.7% |
| FY 2019 | -$474.19M | -455.6% |
| FY 2018 | -$85.34M | -26.4% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Intellia Therapeutics, Inc. make?
Intellia Therapeutics, Inc. (NTLA) reported net income of -$412.69M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Intellia Therapeutics, Inc.'s net income changed over time?
Between fiscal 2015 and fiscal 2025, Intellia Therapeutics, Inc.'s net income declined from -$12.40M to -$412.69M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.